Moffitt — Tampa, Florida

Public research footprint of Moffitt, compiled from the ClinicalTrials.gov public registry.

2,265

Registered studies

709

Active

354

Recruiting now

1,141

Completed

356

Stopped or withdrawn

Most-studied conditions

Pancreatic Ductal Adenocarcinoma (PDAC) · Lung Non-Small Cell Carcinoma · Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma

Recently updated registry entries

NCT03258554 — Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally… (Completed)
NCT07015983 — A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in… (Active Not Recruiting)
NCT07644559 — A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Moffitt?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.